Paolo Sorrentino
Overview
Explore the profile of Paolo Sorrentino including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
787
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Castaldo G, Monaco L, Castaldo L, Sorrentino P
Int J Endocrinol
. 2015 Jun;
2015:723735.
PMID: 26064113
Background. Multiple weight loss failures among obese patients suggest the design of new therapeutic strategies. We investigated the role of 2-week course of enteral treatment with a very low-calorie protein-based...
2.
Schlageter M, Terracciano L, DAngelo S, Sorrentino P
World J Gastroenterol
. 2014 Dec;
20(43):15955-64.
PMID: 25473149
Hepatocellular carcinoma (HCC) is currently the sixth most common type of cancer with a high mortality rate and an increasing incidence worldwide. Its etiology is usually linked to environmental, dietary...
3.
Ferrari R, Hernandez D, Nalls M, Rohrer J, Ramasamy A, Kwok J, et al.
Lancet Neurol
. 2014 Jun;
13(7):686-99.
PMID: 24943344
Background: Frontotemporal dementia (FTD) is a complex disorder characterised by a broad range of clinical manifestations, differential pathological signatures, and genetic variability. Mutations in three genes-MAPT, GRN, and C9orf72--have been...
4.
Perrella A, DAntonio A, Sbreglia C, Sorrentino P, Conca P, Atripaldi L, et al.
Pathog Dis
. 2014 Jun;
72(2):124-30.
PMID: 24891135
We aimed to verify whether CD4(+)/CD25(+) T cells suppress CD4(+) T cells and secrete Granzyme B (GZB) during acute and chronic hepatitis C (CHC) infection. We enrolled 50 subjects: 20...
5.
Attisani M, Pellegrini A, Sorrentino P, Rinaldi M
Heart Surg Forum
. 2014 May;
17(2):E61-3.
PMID: 24808442
Mechanical prosthesis is the first choice for valve replacement at the mitral position in children. Replacement of the original prosthesis because of prosthesis-patient mismatch (PPM) is almost inevitable when prostheses...
6.
DAngelo S, Secondulfo M, De Cristofano R, Sorrentino P
World J Gastroenterol
. 2013 Apr;
19(14):2141-3.
PMID: 23599639
Hepatitis B virus (HBV) is responsible for 50%-80% of cases of hepatocellular carcinoma (HCC) worldwide. Entecavir (ET) is a potent inhibitor of chronic HBV-DNA polymerase, inhibiting both the priming and...
7.
DAngelo S, Secondulfo M, De Cristofano R, Sorrentino P
Future Oncol
. 2013 Apr;
9(4):485-91.
PMID: 23560372
Sorafenib (SO) was the first systemic agent to demonstrate a significant improvement in overall survival in patients with advanced hepatocellular carcinoma (HCC); international guidelines now recommend SO as a first-line...
8.
Loguercio C, Andreone P, Brisc C, Brisc M, Bugianesi E, Chiaramonte M, et al.
Free Radic Biol Med
. 2012 Feb;
52(9):1658-65.
PMID: 22343419
The only currently recommended treatment for nonalcoholic fatty liver disease (NAFLD) is lifestyle modification. Preliminary studies of silybin showed beneficial effects on liver function. Realsil (RA) comprises the silybin phytosome...
9.
Sorrentino P, Castaldo G, Tarantino L, Bracigliano A, Perrella A, Perrella O, et al.
J Gastroenterol Hepatol
. 2011 Dec;
27(4):813-22.
PMID: 22142548
Background And Aim: Refractory ascites in liver-cirrhosis is associated with a poor prognosis. We performed a prospective study to investigate whether aggressive nutritional-support could improve outcomes in cirrhotic patients. Methods:...
10.
Iavarone A, Lore E, De Falco C, Milan G, Mosca R, Pappata S, et al.
Aging Clin Exp Res
. 2011 Jul;
23(5-6):351-6.
PMID: 21720203
Background And Aims: Frontal lobes and executive functions appear to be more vulnerable to normal aging than other cerebral regions and domains. The aim of the study was to evaluate...